Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
IGF
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
cixutumumab
(IMC A12) / Eli Lilly
figitumumab
(CP-751,871) / Novartis
Tepezza
(teprotumumab-trbw) / Roche, Amgen
linsitinib
(ASP7487) / Sling Therap
robatumumab
(SCH 717454) / Merck (MSD)
picropodophyllin
(AXL1717) / Axelar
